Catalyst Wire Dossier Catalyst Wire Dossier

LOW-OGESTREL

NORGESTREL AND ETHINYL ESTRADIOL · Mayne Pharma Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LOW-OGESTREL, covering 2017-08-09 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: LOW-OGESTREL — Supplemental Application (Mayne Pharma Inc.)

See pricing